Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


In wake of Lyme disease vaccine for people, mice may be next in line for shots


As Americans queue up anxiously for flu shots, new research proposes a different sort of mass vaccination program to combat Lyme disease – a vaccine drive for mice.

A Michigan State University disease ecologist leads a novel ecological approach to battle Lyme disease. It proposes that ground zero is the forest floor, and immunizing the tiny critters there offers hope to ultimately reduce the number of dangerous tick bites that infect some 23,000 people in 2002 in the United States. The work is published online this week in the Proceedings of the National Academy of Science. "There is more than one way to try to reduce Lyme disease risk besides relying just on developing vaccines for humans. We also should try ways to intervene in nature because we can potentially help more people by reducing the risk at its source," said Jean Tsao, an assistant professor of fisheries and wildlife, who designed the experiments to evaluate the effectiveness of vaccinating mice.

The research explores reducing the number of infected ticks that transmit the Lyme disease pathogen by vaccinating mice in the forest, thus placing fewer people at risk. The study also paints a more accurate – and surprisingly complex – picture of how Lyme disease is distributed in a forest, and how all forests are not the same. "It shows us that with many emerging infectious diseases originating from animals, no one approach is likely to be a cure-all," Tsao said. "Diseases like this demand you think at the wildlife-community level, not just at the patient level."

Lyme disease is caused by bacteria that multiples and incubates in the bodies of many animals found in the forest. Ticks suck blood from the infected animals, transforming themselves into Lyme delivery systems. The tick’s two-year life cycle allows it to feast first on small animals, such as mice, shrews and raccoons, and later on larger animals such as deer. Humans fall into the mix as they cross paths both in the wilderness and even in yards where wildlife treads.

A vaccine for humans was developed to prevent Lyme disease, but has been withdrawn from the market due to complaints of potentially vaccine-caused arthritis. Reducing the deer population has proven difficult in many areas for practical and political reasons. Targeting mice is important because they are responsible for producing many infected nymphs, the young tick stage that presents the greatest health risk for people.

Tsao decided to take an experimental view of the Lyme disease cycle in nature to get a better understanding of how the Lyme disease pathogen distributes itself among the forest animals. She spent summers in 1998 and 2001 with a team of field assistants in 12 different forested sites in Connecticut, running what amounted to a medical clinic for mice

The mice were trapped live in the one- and two-hectare forest plots. After anesthetizing mice, the researchers would weigh each mouse, draw blood and count ticks. Mice often are loaded with ticks – she’s seen as many as 60 stuck to just one ear of a mouse. All mice were tagged and vaccinated with the Lyme vaccine, then rehydrated with an apple slice and released. In the end, she ended up with medical records of nearly 1,000 mice. "I had to keep track of every mouse, because I wanted to know how many booster shots we gave it, how it responded to the vaccine, and whether the vaccine had failed," she said.

The vaccine’s beauty in the field is that it kills the bacteria in any ticks that feed off the immunized mouse, leaving that tick unthreatening to humans. After immunizing roughly 55 percent of the mouse population over the course of the two studies, researchers saw an overall 16 percent reduction in the prevalence of nymphal infection at locations in which mice had been given vaccine versus placebo. This translates to a possible 27 percent reduction in nymphal infection had all the mice been vaccinated.

But the study also showed that in many forests, vaccinating mice alone wouldn’t be enough. Different forests have different mixes of wildlife, and the conventional wisdom of the mice-deer-tick cycle is too simple to effectively battle Lyme disease. The development of an oral vaccine would allow for greater vaccination coverage of both mice and other animal hosts. "We’ve learned we shouldn’t naively ignore other hosts – shrews, chipmunks, robins, and maybe others," Tsao said. "Unexpectedly, other hosts contribute more to maintaining bacteria than we had thought. Other people might be deterred by the complexity. But just because nature is complex shouldn’t mean we shouldn’t try to design a solution."

Other authors on the paper, "An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle," are J. Timothy Wootton at the University of Chicago; Durland Fish at Yale University School of Medicine; and Jonas Bunikis, Maria Gabriela Luna and Alan Barbour at the University of California at Irvine.

Jean Tsao | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>